Join the Global Summit – ICBSSR 2026, a premier international platform dedicated to innovation, research excellence, and interdisciplinary dialogue in behavioral and social sciences.
📅 March 23–24, 2026 | 📍 Rome, Italy
🔗 icbssr.com
#ICBSSR2026 #GlobalSummit #ResearchConference #SocialSciences
Join the 11th Global Summit on Feminist & LGBTQ+ Studies
📅 24–25 Sept 2026 | 📍 Berlin, Germany | 🌐 Hybrid
📝 Early bird registration open
🔗 genderstudycongress.com/edition2/reg...
#FeministStudies #LGBTQStudies #GenderEquality #Intersectionality #QueerStudies #SocialJustice #Berlin2026 #GlobalSummit
LIVE: Indonesia’s President addresses Davos
Indonesian President Prabowo Subianto gives a special address at the World Economic Forum in Davos. #Davos #Indonesia #PrabowoSubianto #WEF #Leadership #Economy #Asia #GlobalSummit #live #Reuters #News Keep up with the latest news from around the world: (
LIVE: Friedrich Merz special addresses Davos
German Chancellor Friedrich Merz gives a special address at the World Economic Forum. #Davos #Germany #FriedrichMerz #WEF #Economy #Leadership #Business #GlobalSummit #live #Reuters #News Keep up with the latest news from around the world:
🐦 Early Bird Registrations Are Now Open!
24th Global Summit on Nursing Education & Health Care 🩺✨
📅 19–20 October 2026
📍 Tokyo, Japan
🌐 Website: nursingeducation.inovineconferences.com
#earlybirdregistration #nursingeducation #healthcareconference #globalsummit
🌏 24th Global Summit on Nursing Education & Health Care 🩺
📅October 19–20, 2026
📍Tokyo, Japan
📌 Get registered today and secure your slot!
🔗 Website: nursingeducation.inovineconferences.com
#nursingeducation #healthcareconference #globalsummit #nursingleadership
PM Modi to address 2nd WHO Global Summit on Traditional Medicine tomorrow #PMModi #GlobalSummit #TraditionalMedicinetomorrow #socialnewsxyz
Telangana CM meets Kharge, Priyanka Gandhi, briefs them on Global Summit #TelanganaCM #KhargePriyankaGandhi #GlobalSummit #socialnewsxyz
BRS thanks Tony Blair, Subba Rao for speaking ‘truth’ at Global Summit #BRS #TonyBlairSubbaRao #GlobalSummit #socialnewsxyz
#trends today for 'global summit' 'record high' & 'judge refuses'
Click/Tap below:
www.newsmason.com?query=%22glo...
www.newsmason.com?query=%22rec...
www.newsmason.com?query=%22jud...
#globalsummit #recordhigh #judgerefuses
Get Ready for GSFLS-2026!
Join the "11th Global Summit on Feminist and LGBTQ+ Studies" in Boston, June 15-16.
🌐 genderstudycongress.com/edition2
📧 bhushannagari@sciinovhealth.com
📞 +1 732 526 1166
Let’s advance equality—because your voice matters!
#GenderEquality #Feminism #LGBTQ #GlobalSummit
Telangana CM invites Sonia, Rahul, Priyanka for Global Summit #TelanganaCM #SoniaRahulPriyanka #GlobalSummit #socialnewsxyz
Telangana CM meets PM, extends invitation for Global Summit #TelanganaCM #PM #GlobalSummit #socialnewsxyz
Big news, fam
6th International Conference Gynecology Conference is officially live bringing together global experts
👉Full details & registration: gynecologyconference.com
Whatsapp : +1 (778) 508-1009
#internationalconference
#globalsummit
#researchcommunity
#academicevent
Recent issues echo 2023 World Scout Jamboree debacle (dirty toilets, heat sickness). 🏕️ South Korea aims for smooth APEC amid trade disputes. Deputy PM states 99% readiness. 🙏 #GlobalSummit #Reputation #InternationalRelations
What about vascular treatment for persistent limb claudication?
ACR: recs against surgery; escalate IST over surgery + IST
#ACR25 #GlobalSummit
TNFi vs Toci in severe refractory disease
ACR: TNFi over Toci. Toci RCT data is from GCA (GIACTA).
#ACR25 #GlobalSummit
guidelines widely differ on GC dose ACR: 1mg/kg/d EULAR 40-60mg/d Japan 0.5-1mg/kg/d China 25-30mg/d
What about tx?
Steroid for remission induction, with different regimens by different guidelines
#ACR25 #GlobalSummit
ACR: regularly scheduled noninvasive imaging EULAR: imaging is not routinely recommended for pts in remission France: doppler US and angio CT or MRI
What about routine imaging for monitoring?
ACR: regular noninvasive imaging
EULAR: imaging is not routinely recommended
#ACR25 #GlobalSummit
recommendations from EULAR, France, Turkey, and China on who manages TAK
Who manages TAK pts?
In France, the guidelines say it should be a vascular specialist at the helm
In Turkey and China, the guidelines say it should be rheum at the head of the multi-D team
#ACR25 #GlobalSummit
2022 ACR classification criteria for TAK
challenges for guidelines/recs for TAK love or very low level of evidence data from observational studies with small numbers, few RCTs consensus based recs
Haner Direskeneli on Takayasu arteritis
-we have the 2022 ACR classification criteria
-but guidelines are limited by the low level of evidence available
#ACR25 #GlobalSummit
Closing Session – Approaches to the Development of Disease Management Guidelines: An International Perspective (LARS Session) Moderators: Evelyn Hsieh MD, PhD; Eric Matteson MD, MPH Presenters: Haner Direskeneli MD; Liana Fraenkel MD, MPH Global LAR Panelist: Bernhard Hellmich MD; Gilda Ferreira PhD; Bridget Hodkinson PhD ; Chi-Chiu Mok MD, FRCP; Tuhina Neogi, MD, PhD
Last #ACR25 #GlobalSummit - LARs session on guideline development
🖇️WHO definitions and Traditional Medicine Strategy
www.who.int/health-topic...
#ACR25 #GlobalSummit
Traditional medicine can be split into Indigenous (rural) and popular (urban)
#ACR25 #GlobalSummit
Patients move through a plural medical system in which different medical approaches coexist
Traditional medicine in Latam is holistic, multidimensional, and focused on plants, animals, nature
#ACR25 #GlobalSummit
use of traditional medicine in rheumatic diseases in indigenous and non indigenous populations in latin american countries
Ingris del Pilar Pelaez Ballestas - Latin America and traditional medicine for rheum
#ACR25 #GlobalSummit
The multidisciplinary "New Millennium Indian Technology Leadership Initiative" Arthritis Project was undertaken to validate Ayurvedic medicines. Herbal formulations in popular use were selected by expert consensus and standardized using modern tools. Our clinical strategy evolved from simple exploratory evaluations to better powered statistically designed drug trials. The results of the first drug trial are presented here. Five oral formulations (coded A, B, C, D and E), with a common base of Zingiber officinale and Tinospora cordifolia with a maximum of four plant extracts, were evaluated; with placebo and glucosamine as controls. 245 patients suffering from symptomatic OA knees were randomized into seven arms (35 patients per arm) of a double blind, parallel efficacy, multicentric trial of sixteen weeks duration. The groups matched well at baseline. There were no differences for patient withdrawals (17.5%) or adverse events (AE) of mild nature. Intention-to-treat efficacy analysis, demonstrated no significant differences (P < .05) for pain (weight bearing) and WOMAC questionnaire (knee function); placebo response was high. Based on better pain relief, significant (P < .05) least analgesic consumption and improved knee status, "C" formulation was selected for further development. Controlled exploratory drug trials with multiple treatment arms may be used to economically evaluate several candidate standardized formulations.
A 7 arm RCT in knee OA (wow):
pubmed.ncbi.nlm.nih.gov/20981160/
#ACR25 #GlobalSummit
Hydroxychloroquine sulfate (HCQS) is a popular disease-modifying antirheumatic drug (DMARD) despite modest efficacy and toxicity. Ayurveda (ancient India medicinal system) physicians treat rheumatoid arthritis (RA) with allegedly safer herbal formulations. We report a head-to-head comparison in an exploratory drug trial. The objective is to compare standardized Ayurvedic formulations and HCQS in the treatment of RA. One hundred twenty-one patients with active moderately severe RA (ACR 1988 classified) were randomized into a 24-week investigator-blind, parallel efficacy, three-arm (two Ayurvedic and HCQS) multicenter drug trial study; polyherb (Tinospora cordifolia and Zingiber officinale based) and monoherb (Semecarpus anacardium). Study measures included joint counts (pain/tenderness and swelling), pain visual analogue scale, global disease assessments, and health assessment questionnaire. Oral meloxicam (fixed-dosage schedule) was prescribed to all patients during the initial 16 weeks. Patients on prednisolone could continue a fixed stable dose (<7.5 mg daily). Rescue oral use of paracetamol was permitted and monitored. All groups matched well at baseline. An intent-to-treat analysis (ANOVA, significance P < 0.05) did not show significant differences by treatment groups. In the polyherb, monoherb, and HCQS arms, 44%, 36%, and 51%, respectively, showed ACR 20 index improvement. Several efficacy measures improved significantly in the HCQS and polyherb groups with no difference between the groups (corrected P). However, the latter was individually superior to monoherb. Only mild adverse events (gut and skin, and none withdrew) were reported with no differences between the groups. Forty-two patients dropped out. This preliminary drug trial controlled for HCQS demonstrated a standardized Ayurvedic polyherb drug to be effective and safe in controlling active RA. A better-designed study with a longer evaluation period is recommended.
This RCT was a combo of ayurvedic tx with HCQ in RA
pubmed.ncbi.nlm.nih.gov/21773714/
#ACR25 #GlobalSummit
RA-1 contains ashwagandha, Boswellia serrrata, ginger, turmeric ITT no benefit vs pbo though other endpoints better than pbo
RA-1, a combo of ayurvedic tx, was studied in an RCT
#ACR25 #GlobalSummit
